Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01705093
Other study ID # 333071
Secondary ID
Status Completed
Phase Phase 2
First received August 31, 2012
Last updated July 13, 2017
Start date May 2012
Est. completion date January 2015

Study information

Verified date July 2017
Source University of California, Davis
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The prevalence of childhood obesity has been increasing over the past couple of decades. Similar to adults, overweight and obesity in young children and adolescents is associated with an increased number of cardiovascular risk factors including dyslipidemia, hypertension, insulin resistance and Type 2 diabetes. Epidemiological and clinical studies suggest that foods and ingredients rich in select flavonoids, such as cocoa, red grape products, tea, citrus fruits, and strawberries are protective against the development of cardiovascular disease. Strawberries are rich in flavonoids, particularly anthocyanins, flavanols, flavonols, ellagic acid and its glucose ester, ellagitanin. A number of in vitro studies have observed that these isolated compounds, as well as strawberry extracts have the potential to affect outcomes of cardiovascular health, including vascular reactivity, cellular signaling and oxidant defense6,7. We hypothesize that strawberry intake will lead to improvements in select measures of cardiovascular function in overweight and obese adolescent males.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date January 2015
Est. primary completion date January 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 14 Years to 18 Years
Eligibility Inclusion Criteria:

- Male subjects, age 14 - 18 years.

- BMI for age and gender >75th percentile (based on CDC growth charts)

- Subject is willing and able to comply with the study protocols.

Exclusion Criteria:

- Inability to wear PAT probes

- Inability to remain still and remain quiet during test procedures

- BMI for age and gender = 75th percentile (based on CDC growth charts)

- The use of medications that affect vascular function

- Regular use of dietary supplements during the last 6 months

- Blood pressure for age, gender and height =95th percentile

- Chronic/routine high intensity exercise or current participation in a sports program

- Self/Parent reported use of anticoagulation agents including NSAIDs

- Self/Parent reported use of oral cortisone or other immunosuppressive agents,

- Self/Parent reported underlying neoplasia or immunological disease

- Self/Parent reported diabetes

- Food faddists or those taking a non-traditional diet

- Allergies to fruit

- Abnormal Liver, CBC or Chemistry panels (laboratory values outside the reference

- range) if determined to be clinically significant by the study physician.

- Self/Parent reported malabsorption (e.g. difficulty digesting or absorbing nutrients from food, potentially leading to bloating, cramping or gas).

- Asthma (can be worsened by mild to moderate food allergies).

Study Design


Intervention

Dietary Supplement:
flavonoid-rich freeze-dried strawberry powder
50g of flavonoid-rich freeze-dried strawberry powder
macronutrient-matched control powder
50g macronutrient-matched powder that will lack strawberry flavonoids

Locations

Country Name City State
United States Ragle Human Nutrition Research Center, Academic Surge, UC Davis Davis California

Sponsors (1)

Lead Sponsor Collaborator
University of California, Davis

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Vascular function measured by peripheral arterial tonometry Change from baseline at 1 hour and 1 week post consumption of freeze-dried strawberry powder or control powder Change from baseline in vascular function at 1 hour and 1 week
See also
  Status Clinical Trial Phase
Completed NCT02122198 - Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women N/A
Completed NCT02502812 - Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects Phase 1
Recruiting NCT04216342 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers Phase 1
Completed NCT03654313 - Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus Phase 1
Completed NCT03646656 - Heart Health Buddies: Peer Support to Decrease CVD Risk N/A
Completed NCT02081066 - Identification of CETP as a Marker of Atherosclerosis N/A
Completed NCT02147626 - Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia N/A
Not yet recruiting NCT06405880 - Pharmacist Case Finding and Intervention for Vascular Prevention Trial N/A
Recruiting NCT03095261 - Incentives in Cardiac Rehabilitation N/A
Completed NCT02589769 - Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons N/A
Completed NCT02868710 - Individual Variability to Aerobic Exercise Training N/A
Completed NCT02711878 - Healing Hearts and Mending Minds in Older Adults Living With HIV N/A
Completed NCT02998918 - Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL N/A
Not yet recruiting NCT02578355 - National Plaque Registry and Database N/A
Recruiting NCT02885792 - Coronary Artery Disease in Patients Suffering From Schizophrenia N/A
Completed NCT02640859 - Investigation of Metabolic Risk in Korean Adults
Completed NCT02652975 - Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium N/A
Completed NCT02272946 - Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk Phase 2
Completed NCT02657382 - Mental Stress Ischemia: Biofeedback Study N/A
Recruiting NCT02265250 - Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment